>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Armstrong World Industries (AWI) upgraded to Outperform from In Line at Evercore ISI, tgt $200
    • Celestica (CLS) upgraded to Buy from Hold at TD Securities, tgt $430
    • Centene (CNC) upgraded to Buy from Underperform at BofA Securities, tgt $60
    • Centene (CNC) upgraded to Overweight from Neutral at Cantor Fitzgerald, tgt $60
    • Crane (CR) upgraded to Buy from Hold at Stifel, tgt $215
    • Elevance Health (ELV) upgraded to Buy from Neutral at BofA Securities, tgt $435
    • Franklin Resources (BEN) upgraded to Equal Weight from Underweight at Barclays, tgt $31
    • MaxLinear (MXL) upgraded to Buy from Hold at Loop Capital, tgt $75
    • Molina Healthcare (MOH) upgraded to Buy from Underperform at BofA Securities, tgt $250
    • NeoGenomics (NEO) upgraded to Outperform from Market Perform at Leerink Partners; tgt $25
    • Nokia (NOK) upgraded to Buy from Neutral at Arete
    • Procore Technologies (PCOR) upgraded to Outperform from Market Perform at Citizens, tgt $71
    • Qiagen (QGEN) upgraded to Outperform from Neutral at Robert W. Baird, tgt $43
    • Radian Group (RDN) upgraded to Buy from Underperform at BofA Securities, tgt $43
    • Spotify (SPOT) upgraded to Buy from Accumulate at IndeRes, tgt $570
    • Spotify (SPOT) upgraded to Buy from Neutral at Rosenblatt; tgt $500
    • Tamboran Resources (TBN) upgraded to Outperform from Sector Perform at RBC Capital, tgt $55
    • Telecom Argentina (TEO) upgraded to Overweight from Neutral at JPMorgan, tgt $16
    • T-Mobile (TMUS) upgraded to Outperform from Perform at Oppenheimer, tgt $260
    • Victoria's Secret (VSCO) upgraded to Buy from Neutral at BofA Securities, tgt $68
    • Zeta Global (ZETA) upgraded to Overweight from Sector Weight at KeyBanc, tgt $22
  • Downgrades:
    • Brown-Forman (BF.B) downgraded to Underweight from Neutral at JPMorgan, tgt $23
    • Clearwater Paper (CLW) downgraded to Hold from Buy at TD Cowen; tgt $17
    • MercadoLibre (MELI) downgraded to Neutral from Buy at UBS, tgt $2,050
    • Purple Innovation (PRPL) downgraded to Sector Weight from Overweight at KeyBanc
    • Qualys (QLYS) downgraded to Market Perform from Outperform at William Blair
    • Rapid7 (RPD) downgraded to Market Perform from Outperform at William Blair
    • StoneCo (STNE) downgraded to Neutral from Buy at Goldman, tgt $14
    • Sysco (SYY) downgraded to Hold from Buy at Deutsche Bank, tgt $84
    • Tenable (TENB) downgraded to Market Perform from Outperform at William Blair
    • Universal Health (UHS) downgraded to Mkt Perform from Outperform at Raymond James
  • Others:
    • Aktis Oncology (AKTS) initiated with an Outperform at William Blair
    • Alibaba (BABA) initiated with an Outperform at BNP Paribas, tgt $209
    • Corbus Pharmaceuticals (CRBP) initiated with a Buy at Guggenheim, tgt $45
    • Klaviyo (KVYO) resumed with an Overweight at Morgan Stanley, tgt $29
    • Legence (LGN) initiated with a Buy at Loop Capital, tgt $96
    • Wave Life Sciences (WVE) assumed with a Buy at Truist, tgt $15